Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting
Ayad K Ali, Abraham G HartzemaDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USABackground: Omalizumab is a monoclonal antibody, indicated for the treatment of severe allergic asthma. In Europe, there have been concerns about the cardio...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-05-01
|
| Series: | Journal of Asthma and Allergy |
| Online Access: | http://www.dovepress.com/assessing-the-association-between-omalizumab-and-arteriothrombotic-eve-a9811 |